TY - JOUR ID - 8580 TI - Remyelination improvement after neurotrophic factors secreting cells transplantation in rat spinal cord injury JO - Iranian Journal of Basic Medical Sciences JA - IJBMS LA - en SN - 2008-3866 AU - Razavi, Shahnaz AU - Ghasemi, Nazem AU - Mardani, Mohammad AU - Salehi, Hossein AD - Department of Anatomical Science, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran Y1 - 2017 PY - 2017 VL - 20 IS - 4 SP - 392 EP - 398 KW - Lysolecithin lesion KW - Myelination KW - Neurotrophic factor-secreting cells (NTF-SCs) KW - Spinal cord injury DO - 10.22038/ijbms.2017.8580 N2 - Objective(s): Neurotrophic factors secreting cells (NTS-SCs) may be a superior cell source for cell-based therapy in neurodegenerative diseases. NTS-SCs are able to secrete some neurotrophic Such as nerve growth factor and glia-derived neurotrophic factor. Our primary aim was to assess transplantation of neurotrophic factor secreting cells derived from human adipose-derived stem cells (hADSCs) into the damaged spinal cord rats and determine the potential of these cells in remyelination. Materials and Methods: To this end, 40 adult male Wistar rats were categorized into four groups including; control, lysolecithin (Lysophosphatidylcholines or LPC), vehicle, and NTS-SCs transplan-tation. Local demyelination was induced using LPC injection into the lateral column of spinal cord. Seven days after the lysolecithin lesion, the cells transplantation was performed. The ultrastructure of myelinated fibers was examined with a transmission electron microscope to determine the extent of myelin destruction and remyelinization 4 weeks post cell transplantation. Moreover, the presence of oligodendrocyte in the lesion of spinal cord was assessed by immunohistochemistry procedure. Results: The results of current study indicated that in NTF-SCs transplantation group, the remyelination process and the mean of myelin sheath thickness as well as axonal diameters were significantly higher than other groups (P<0.001). Furthermore, immunohistochemistry analysis revealed that in NTF-SCs transplantation group more than 10 percent of transplanted cells were positive for specific markers of oligodendrocyte cells. Conclusion: NTF-SCs transplantation represents a valuable option for cell-based therapy in the nervous tissue damages. UR - https://ijbms.mums.ac.ir/article_8580.html L1 - https://ijbms.mums.ac.ir/article_8580_a0ba8219c057d8eae4de0069f2468d07.pdf ER -